Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 10, 2010, Pages 1519-1521

  He, Yu Guang ^a   Wang, Hao ^a   Zhao, Biren ^a   Lee, Jason ^a   Bahl, Dinesh ^a   McCluskey, Jessica ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bevacizumab; Coats' disease; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; EXUDATIVE RETINITIS; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA EDEMA; SCHOOL CHILD; SUBRETINAL FLUID; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; BODY FLUID; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATE; FLUORESCENCE ANGIOGRAPHY; INJECTION; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA BLOOD VESSEL; RETINAL DISEASES; TELANGIECTASIS; VERY ELDERLY; VITREOUS BODY;

ADULT; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; AQUEOUS HUMOR; BODY FLUIDS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; RETINAL DETACHMENT; RETINAL DISEASES; RETINAL VESSELS; TELANGIECTASIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77956189058     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1366-1     Document Type: Article

References (10)

1. JA Shields CL Shields 2001 Review: Coats' disease. The 2001 LuEsther T. Mertz lecture Retina 22 80 91 10.1097/00006982-200202000-00014
2. SW Silodor JJ Augsburger JA Shields, et al. 1988 Natural history and management of advanced Coats' disease Ophthalmic Surg 19 89 93 1:STN:280:DyaL1c7lslGjtw%3D%3D 3347463
3. AC Schefler AM Berrocal TG Murray 2008 Advanced Coats' disease: management with repetitive aggressive laser ablation therapy Retina 28 S28 S41 10.1097/IAE.0b013e318163cd7c
4. JH Jun YC Kim KS Kim 2008 Resolution of severe macular edema in adult Coats' disease with intravitreal triamcinolone and bevacizumab injection Korean J Ophthalmol 22 190 193 10.3341/kjo.2008.22.3.190 18784449
5. M Cakir O Cekic F Yilmaz 2008 Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease Journal of AAPOS 12 309 311 10.1016/j.jaapos.2008.01.009 18589387
6. P Venkatesh S Mandal S Garg 2008 Management of Coats' disease with bevacizumab in 2 patients Can J Ophthalmol 43 245 246 10.3129/I08-028 18347637
7. Y Sun A Jain DM Moshfeghi 2007 Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium Graefes Arch Clin Exp Ophthalmol 245 1387 1388 10.1007/s00417-007-0559-8 1:CAS:528:DC%2BD2sXptVGms70%3D 17342503
8. UFO Luhmann J Lin N Acar S Lammel S Feil C Grimm MW Seeliger HP Hammes W Berger 2005 Role of the Norrie disease pseukoglioma gene in sprouting angiogenesis during development of the retinal vasculature Invest Ophthalmol Vis Sci 46 3372 3382 10.1167/iovs.05-0174 16123442
9. GC Black R Perveen R Bonshek M Cahill J Clayton-Smith C Lloyd D McLeod 1999 Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis Hum Mol Genet 8 2031 2035 10.1093/hmg/8.11.2031 1:CAS:528:DyaK1MXmslemsbc%3D 10484772
10. S Kaul M Uparkar K Mody J Walinjkar M Kothari S Natarajan 2010 Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children Indian J Ophthalmol 58 76 78 10.4103/0301-4738.58480 20029154